Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells - Kitiya Rujimongkon; Patthamapon Adchariyasakulchai; Chanoknun Boonyaratsewee; Kantasorn Horpratraporn; Wannarasmi Ketchart (PLoS ONE, 2026)